GLP-1
Semaglutide
Acts on the GLP-1 pathway to reduce appetite. Results vary and are not guaranteed.
- The most studied of the three
- Once-weekly injection
- Also acts on blood-sugar regulation
$250/month
View semaglutideMedical weight loss · Wesley Chapel & Tampa
Provider-guided programs built around once-weekly GLP-1 injections — semaglutide $250 a month, tirzepatide and retatrutide $400 — with a plan built around you and real nutritional guidance.
Come in, or do it by telehealth — whichever suits you. You talk it through with a provider who builds a game plan around what is right for you, not a template.
One quick injection a week — in the lounge or take-home — plus nutrition guidance, optional lipotropic boosters, and progress tracking that keeps you honest.
These are compounded preparations. They are not FDA-approved to prevent, treat or cure any condition. Individual results vary and no result is guaranteed. Nothing on this site is medical advice.
GLP-1
Acts on the GLP-1 pathway to reduce appetite. Results vary and are not guaranteed.
$250/month
View semaglutideGLP-1 + GIP · dual-action
Acts on two pathways, GLP-1 and GIP. Results vary and are not guaranteed.
$400/month
View tirzepatideTriple-action · investigational
Acts on GLP-1, GIP and glucagon pathways. Investigational — it holds no FDA approval for any condition and remains in clinical trials.
$400/month
View retatrutideMedication is one part. Food, movement and follow-up are the rest. Provider-supervised from the first consult
Semaglutide is $250 per month at Optimal Wellness. Tirzepatide and Retatrutide are $400 per month. That price includes provider supervision start to finish, nutritional guidance and meal planning, and hormone-balance support — there's no separate program fee stacked on top. Every program starts with a consult, where the provider builds a plan around you rather than a template. Bloodwork is available if you want it, billed separately.
Semaglutide acts on the GLP-1 pathway and is the most studied of the three. Tirzepatide acts on two pathways, GLP-1 and GIP. Retatrutide acts on three, but it is investigational — it holds no FDA approval for any condition and remains in clinical trials. Results vary and are not guaranteed. Your provider matches you to one at your consult. It isn't a menu you order from.